We are monitoring the impact of COVID-19 on Europe African Horse Sickness Treatment Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 5486
Share on
Share on

Europe African Horse Sickness Treatment Market Research Report - Segmented By Clinical Form, Diagnosis & Country (UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic & Rest of Europe) - Industry Size, Share, Trends, Growth, Forecasts | 2021 to 2026

Pulished: April, 2021
ID: 5486
Pages: 145

The size of the European African Horse Sickness Treatment Market is predicted to grow at a moderate CAGR during the forecast period.

Increased awareness of HAT and rising demand for improved diagnostic tests are a few factors promoting the growth rate of the African horse sickness treatment market in the European region.  The African horse sickness treatment market is expected to grow rapidly as the incidence of African horse sickness among horses, mules, and donkeys in Europe rises.  According to statistics, there are an anticipated 266 occurrences of African Horse Sickness in the remaining seven months of 2020. As a result of the increased prevalence rate of African horse sickness, the need for African horse sickness therapy is predicted to rise.

The growing number of non-government and government programs to raise awareness about the importance of immunization in preventing life-threatening illnesses in animals is expected to support the growth of the European African Horse Sickness Treatment market. AHS is a highly contagious viral disease that can result in severe economic losses. Fever, tiredness, and respiratory issues such as difficulty breathing are all symptoms of AHS. In addition, in horses infected with this virus, neurological symptoms may appear in some circumstances.

Over the last few months, almost every market in Europe has suffered a setback due to the COVID-19 outbreak. This can be ascribed to significant interruptions in their respective manufacturing and supply-chain operations due to numerous precautionary lockdowns and other restrictions imposed by regulatory bodies across the market.

This research report on the Europe African horse sickness treatment market has been segmented and sub-segmented into the following categories

By Clinical Form:

  • Dikkop or Cardiac form
  • Dunkop or Pulmonary form
  • horse sickness fever
  • mixed form

By Diagnosis:

  • preventive treatment
    • vaccines and diagnostic tests
    • Serological Tests

By Country:

  • UK
  • France
  • Spain
  • Germany
  • Italy
  • Russia
  • Sweden
  • Denmark
  • Switzerland
  • Netherlands
  • Turkey
  • Czech Republic
  • Rest of Europe

Geographically, Europe held the second-largest share in the global market in 2020. With its expanding global significance, businesses in the African Horse Sickness Treatment sector are now more engaged with cutting-edge approaches such as targeted marketing and CSR activities. A striking tendency that can be seen across the board is that these businesses are now aiming to handle a certain business-related activity in a country with favorable legislation. As a result, many organizations can save costs while still employing market experts at every important juncture of their operations.

Authorities in rising countries like Germany and the U.K are establishing strategies to entice foreign investors into their industrial sectors by cutting trade tariffs and duties to create more jobs. The African Horse Sickness Treatment market is examined in-depth on a regional level, detailing its competitive landscape, future growth possibilities, and potential hazards and providing data on a variety of topics.

The African horse sickness treatment (AHS) market will be advantageous for various preventive vaccines in research and development efforts, contributing to market growth. In addition, the existence of standard operating procedures and guidelines for the African horse sickness condition has boosted the market for African horse sickness therapy across all regions.

Consumer demand has also decreased in Germany, as people are now more focused on removing non-essential expenses from their budgets, as the general economic situation of most people has been adversely impacted by this pandemic.

KEY MARKET PLAYERS:

Companies playing a vital role in the European African horse sickness treatment market profiled in the report are Veterinary Serum and Vaccine Research Institute and Onderstepoort Biological Products SOC Ltd.

1. Introduction     

               1.1 Market Definition                    

               1.2 Study Deliverables                   

               1.3 Base Currency, Base Year and Forecast Periods

               1.4 General Study Assumptions                  

2. Research Methodology               

               2.1 Introduction               

               2.2 Research Phases                      

   2.2.1 Secondary Research            

   2.2.2 Primary Research  

   2.2.3 Econometric Modelling      

   2.2.4 Expert Validation   

               2.3 Analysis Design                         

               2.4 Study Timeline                          

3. Overview          

               3.1 Executive Summary                 

               3.2 Key Inferences                          

               3.3 Epidemiology  

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)             

               4.1 Market Drivers                         

               4.2 Market Restraints                    

               4.3 Key Challenges                         

               4.4 Current Opportunities in the Market                 

5. Market Segmentation   

               5.1 Clinical forms 

   5.1.1 Introduction           

   5.1.2 Dikkop or Cardiac form       

   5.1.3 Dunkop or Pulmonary form

   5.1.4 Horse sickness fever            

   5.1.5 Mixed form             

   5.1.6 Y-o-Y Growth Analysis, By Clinical forms      

   5.1.7 Market Attractiveness Analysis, By Clinical forms      

   5.1.8 Market Share Analysis, By Clinical forms      

               5.2 Diagnosis                    

   5.2.1 Introduction           

   5.2.2 Prevention treatment          

                  5.2.2.1 Vaccines

   5.2.3 Diagnostic tests     

                  5.2.3.1 Laboratory tests for viral antigens

                  5.2.3.2 Serological tests

   5.2.4 Y-o-Y Growth Analysis, By Diagnosis             

   5.2.5 Market Attractiveness Analysis, By Diagnosis             

   5.2.6 Market Share Analysis, By Diagnosis              

6. Geographical Analysis   

               6.1 Introduction               

   6.1.1 Regional Trends     

   6.1.2 Impact Analysis      

   6.1.3 Y-o-Y Growth Analysis         

                  6.1.3.1 By Geographical Area

                  6.1.3.2 By Clinical forms

                  6.1.3.3 By Diagnosis

   6.1.4  Market Attractiveness Analysis       

                  6.1.4.1 By Geographical Area

                  6.1.4.2 By Clinical forms

                  6.1.4.3 By Diagnosis

   6.1.5  Market Share Analysis        

                  6.1.5.1 By Geographical Area

                  6.1.5.2 By Clinical forms

                  6.1.5.3 By Diagnosis

               6.2 U.K                

               6.3 Spain 

               6.4 Germany                     

               6.5 Italy  

               6.6 France    

               6.7 Rest of Europe                     

7. Strategic Analysis           

               7.1 PESTLE analysis                        

   7.1.1 Political    

   7.1.2 Economic 

   7.1.3 Social        

   7.1.4 Technological        

   7.1.5 Legal         

   7.1.6 Environmental       

               7.2 Porter’s Five analysis              

   7.2.1 Bargaining Power of Suppliers         

   7.2.2 Bargaining Power of Consumers     

   7.2.3 Threat of New Entrants      

   7.2.4 Threat of Substitute Products and Services  

   7.2.5 Competitive Rivalry within the Industry        

8. Market Leaders' Analysis             

               8.1 Veterinary Serum and Vaccine Research Institute                        

   8.1.1 Overview  

   8.1.2 Product Analysis    

   8.1.3 Financial analysis   

   8.1.4 Recent Developments         

   8.1.5 SWOT analysis       

   8.1.6 Analyst View           

               8.2 Onderstepoort Biological Products SOC                          

9. Competitive Landscape               

               9.1 Market share analysis 

               9.2 Merger and Acquisition Analysis                         

               9.3 Agreements, Collaborations, and Joint Ventures

               9.4 New Product Launches                          

10. Market Outlook and Investment Opportunities                

Appendix               

               a) List of Tables                

               b) List of Figures              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • The segment-level analysis in terms of product type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Europe African Horse Sickness Treatment Market By Clinical forms, From 2021 to 2026 ( USD Billion )
  2. Europe Dikkop or Cardiac form Market By Region, From 2021 to 2026 ( USD Billion )
  3. Europe Dunkop or Pulmonary form Market By Region, From 2021 to 2026 ( USD Billion )
  4. Europe Horse sickness fever Market By Region, From 2021 to 2026 ( USD Billion )
  5. Europe Mixed form Market By Region, From 2021 to 2026 ( USD Billion )
  6. Europe African Horse Sickness Treatment Market By Diagnosis, From 2021 to 2026 ( USD Billion )
  7. Europe Prevention treatment  Market By Region, From 2021 to 2026 ( USD Billion )
  8. Europe Diagnostic tests  Market By Region, From 2021 to 2026 ( USD Billion )
  9. U.K. African Horse Sickness Treatment Market By Clinical forms , From 2021 to 2026 ( USD Billion )
  10. U.K. African Horse Sickness Treatment Market By Diagnosis, From 2021 to 2026 ( USD Billion )
  11. Germany African Horse Sickness Treatment Market By Clinical forms , From 2021 to 2026 ( USD Billion )
  12. Germany African Horse Sickness Treatment Market By Diagnosis, From 2021 to 2026 ( USD Billion )
  13. France African Horse Sickness Treatment Market By Clinical forms , From 2021 to 2026 ( USD Billion )
  14. France African Horse Sickness Treatment Market By Diagnosis, From 2021 to 2026 ( USD Billion )
  15. Italy African Horse Sickness Treatment Market By Clinical forms , From 2021 to 2026 ( USD Billion )
  16. Italy African Horse Sickness Treatment Market By Diagnosis, From 2021 to 2026 ( USD Billion )
  17. Spain African Horse Sickness Treatment Market By Clinical forms , From 2021 to 2026 ( USD Billion )
  18. Spain African Horse Sickness Treatment Market By Diagnosis, From 2021 to 2026 ( USD Billion )

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample